食管癌切除术后症状性膈疝的发生率与治疗
该回顾性分析基于2005年1月至2015年12月的前瞻性数据库,纳入851例食管或胃食管交界癌切除患者,症状性膈疝发生率为2.5%(21例),微创Ivor Lewis术后发生率最高(9.4%),预防性膈肌脚修补未显著降低发生率(2.1% vs 2.7%,p=0.608)。
要点
- 微创Ivor Lewis术后症状性膈疝发生率最高(9.4%),显著高于其他术式(p=0.002)。
- 预防性膈肌脚修补未降低症状性膈疝发生率(2.1% vs 2.7%,p=0.608)。
- 术后复发4例(19.0%),腹腔镜修补后3例,开腹修补后1例。
核心结论
- 食管切除术后症状性膈疝发生率为2.5%,微创Ivor Lewis术后发生率最高(9.4%),预防性膈肌脚修补未显著降低疝发生率。
研究设计与样本
- 利用前瞻性数据库回顾性分析2005年1月至2015年12月连续接受食管切除术的患者,共纳入851例。
主要发现
- 851例中21例(2.5%)诊断为症状性膈疝;微创食管切除术后15例(4.3%),开胸食管切除术后6例(1.2%)(p=0.004)。
- 微创Ivor Lewis术后发生率最高(9.4%;p=0.002),与其他术式相比。
- 预防性膈肌脚修补未降低症状性膈疝发生率(2.1% vs 2.7%;p=0.608)。
- 11例采用Prolene垫片(Ethicon, Somerville, NJ)加强膈肌脚修补;主要并发症(Clavien-Dindo分级>IIIb)3例,均发生于开腹修补后(n=9)。
- 复发4例(19.0%),腹腔镜修补后3例,开腹修补后1例。
临床怎么用
- 原文指出,尽管预防性膈肌脚修补目前是微创食管切除术患者的标准治疗,但本研究未发现其显著降低疝发生率。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Diaphragmatic hernias after esophagectomy are mostly asymptomatic. However, they can also manifest with severe complications and be associated with high morbidity and mortality rates. The aims of this study were to assess the incidence, predictive factors, and preferred treatment of symptomatic diaphragmatic hernias and to evaluate the role of prophylactic cruroplasty in patients after esophagectomy for carcinomas of the esophagus or gastroesophageal junction. METHODS: A prospective database was used to retrospectively analyze consecutive patients who underwent esophagectomy between January 2005 and December 2015. RESULTS: A symptomatic diaphragmatic hernia was diagnosed in 21 (2.5%) of 851 included patients; 15 (4.3%) after 345 minimally invasive esophagectomies and 6 (1.2%) after 506 open esophagectomies (p = 0.004). Minimally invasive Ivor Lewis procedures had the highest incidence (9.4%; p = 0.002) as compared with all other procedures. Prophylactic cruroplasty did not decrease the incidence of symptomatic diaphragmatic hernias (2.1% vs 2.7%; p = 0.608). Surgical treatment consisted of cruroplasty, with reinforcement of Prolene pledgets (Ethicon, Somerville, NJ) in 11 patients. Major complications (Clavien-Dindo grade >IIIb) occurred in 3 patients, all after open repair (n = 9). Recurrences were found in 4 patients (19.0%), three after laparoscopic repair and one after open repair. CONCLUSIONS: The incidence of symptomatic diaphragmatic hernia after esophagectomy was 2.5%, with the highest incidence after minimally invasive Ivor Lewis esophagectomy (9.4%) as compared with other procedures. Although prophylactic cruroplasty is now the standard of care in patients undergoing minimally invasive esophagectomy, a significant lower hernia rate was not found in this study.
引用
- Gooszen JAH, Slaman AE, van Dieren S, et al. Incidence and Treatment of Symptomatic Diaphragmatic Hernia After Esophagectomy for Cancer. Ann Thorac Surg. 2018. PMID: 29555244. doi:10.1016/j.athoracsur.2018.02.034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。